Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
アミロイド形成疾患の予防および治療剤
Document Type and Number:
Japanese Patent JP4677333
Kind Code:
B2
Abstract:
The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A² peptide or an antibody thereto.

Inventors:
Dale B. Schenk
Application Number:
JP2005346462A
Publication Date:
April 27, 2011
Filing Date:
November 30, 2005
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Janssen Alzheimer Immunotherapy
International Classes:
A61K48/00; A61K9/26; G01N33/50; A61K33/06; A61K35/76; A61K38/00; A61K38/17; A61K38/19; A61K38/28; A61K39/00; A61K39/39; A61K39/395; A61K47/02; A61K47/24; A61K47/34; A61P25/28; C07H21/04; C07K14/47; C07K16/18; C07K16/40; C12N7/00; C12N15/09; G01N33/15; G01N33/53; G01N33/567
Domestic Patent References:
JP9510732A
JP9509182A
JP6502387A
JP6502069A
JP7508512A
JP8511236A
JP5508385A
JP5506459A
JP8508978A
JP6502410A
JP64500036A
JP7503255A
JP6141882A
Foreign References:
WO1996014061A1
WO1997003192A1
WO1997037031A1
WO1996029421A1
WO1997036601A1
WO1997028816A1
Other References:
SOLOMON, B., et al.,Disaggregation of Alzheimer β-amyloid by site-directed mAb,Proceedings of the National Academy of Sciences of the United States of America,1997年 4月15日,Vol.94, No.8,p.4109-4112
Attorney, Agent or Firm:
Patent business corporation Odashima patent office